Author details

Full Name

Peter McGuffin

Affiliation

ORCID

Career Start Year

1976

Papers

531

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34763734	Dimensions of temperament and character as predictors of antidepressant discontinuation, response and adverse reactions during treatment with nortriptyline and escitalopram.	Psychol Med	2023
37777856	GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.	Am J Psychiatry	2023
33783297	Genome-wide association study of suicidal behaviour severity in mood disorders.	World J Biol Psychiatry	2021
32064741	Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.	Addict Biol	2021
34002096	Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology.	Nat Genet	2021
33674754	Correction: Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder.	Mol Psychiatry	2021
31318184	Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.	J Clin Psychiatry	2019
30445390	Family functioning, trauma exposure and PTSD: A cross sectional study.	Journal of Affective Disorders	2019
30698114	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.	Br J Psychiatry	2019
31164008	GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.	Am J Psychiatry	2019
31003785	Genome-wide Burden of Rare Short Deletions Is Enriched in Major Depressive Disorder in Four Cohorts.	Biol Psychiatry	2019
29160301	New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.	Pharmacogenomics J	2018
28867280	Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples.	Brain Behav Immun	2018
29032294	One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression.	Journal of Psychiatric Research	2018
30104601	Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP).	Transl Psychiatry	2018
30135031	Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies.	Eur Neuropsychopharmacol	2018
30130674	Genetic disposition to inflammation and response to antidepressants in major depressive disorder.	J Psychiatr Res	2018
30080747	Unravelling the GSK3Î²-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder.	Psychiatr Genet	2018
29615645	Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables.	Sci Rep	2018
29700475	Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.	Nat Genet	2018
28159590	Pharmacogenetics of antidepressant response: A polygenic approach.	Prog Neuropsychopharmacol Biol Psychiatry	2017
28350396	Genetic effects influencing risk for major depressive disorder in China and Europe.	Transl Psychiatry	2017
28642257	Interaction between the <i>FTO</i> gene, body mass index and depression: meta-analysis of 13701 individuals.	Br J Psychiatry	2017
28977440	Advancing psychiatric genetics through dissecting heterogeneity.	Human Molecular Genetics	2017
28879470	Childhood maltreatment and the medical morbidity in bipolar disorder: a case-control study.	International Journal of Bipolar Disorders	2017
28478783	Genetic and other risk factors for suicidal ideation and the relationship with depression.	Psychological Medicine	2017
28285246	The DAOA gene is associated with schizophrenia in the Taiwanese population.	Psychiatry Research	2017
28257825	Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.	Brain Behav Immun	2017
27696737	Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression.	Am J Med Genet B Neuropsychiatr Genet	2017
28218048	An Erudite Encounter with: Peter McGuffin CBE.	Australian and New Zealand Journal of Psychiatry	2017
28102561	Stressful life events and catechol-O-methyl-transferase (COMT) gene in bipolar disorder.	Depression and Anxiety	2017
26621261	Transcriptomics and the mechanisms of antidepressant efficacy.	Eur Neuropsychopharmacol	2016
25861698	Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder.	Biol Psychiatry	2016
27151072	Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis.	Br J Psychiatry	2016
26974950	Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.	Nat Neurosci	2016
26752265	Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma.	Nat Genet	2016
27089522	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.	J Psychiatr Res	2016
27406289	Machine learning, statistical learning and the future of biological research in psychiatry.	Psychological Medicine	2016
26989099	Evaluation of the validity and utility of a transdiagnostic psychosis dimension encompassing schizophrenia and bipolar disorder.	British Journal of Psychiatry	2016
26526099	Polygenic interactions with environmental adversity in the aetiology of major depressive disorder.	Psychol Med	2016
26440730	Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones.	Pharmacogenomics Journal	2016
25108803	DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.	Biol Psychiatry	2015
25917933	A genome-wide association study of suicide severity scores in bipolar disorder.	J Psychiatr Res	2015
25745134	Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder.	Br J Psychiatry	2015
25698070	Familiality and SNP heritability of age at onset and episodicity in major depressive disorder.	Psychol Med	2015
25656077	The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses.	Am J Med Genet B Neuropsychiatr Genet	2015
25903154	A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder.	BMC Med	2015
25761838	Exploring the role of drug-metabolising enzymes in antidepressant side effects.	Psychopharmacology (Berl)	2015
26429689	Authors' reply.	British Journal of Psychiatry	2015
26302953	The successful search for genetic loci associated with depression.	Genome Medicine	2015